BioWorld

July 19, 2006

Senate OKs ESC Funding Bill, But Quick Veto Likely

WASHINGTON - Although the Senate voted on Tuesday to pass a bill to expand federal funding for embryonic stem cell research, President Bush is likely to soon stop the measure in its tracks. (BioWorld Today) Read More

Crucell Shares Fall After Aerugen Program Ended

FDA Wants More On CAIV-T, But MedImmune On Course

Cadence Files For $86M IPO; Osiris Provides Price Range

Other News To Note

Clinic Roundup

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...